ACM
BSX icon

Americafirst Capital Management’s Boston Scientific BSX Stock Holding History

Americafirst Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-43,060
Closed -$571K – 264
2014
Q4 		$571K Sell
43,060
-17,550
-29% -$224K 0.28% 127
2014
Q3 		$716K Buy
+60,610
New +$763K 0.35% 111

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Americafirst Capital Management's BSX Position: Q1 2015 in Review

Americafirst Capital Management sold out of Boston Scientific (BSX) in Q1 2015, closing a stake of 43,060 shares — an estimated $571K sold.

Americafirst Capital Management first reported a position in BSX in Q3 2014 and held it in 2 quarters. The position peaked at $716K in Q3 2014. 471 funds tracked by Wall St. Rank hold BSX as of Q1 2015.

  • Americafirst Capital Management reported no remaining Boston Scientific position as of Q1 2015 after selling out during the quarter.
  • Americafirst Capital Management sold 43,060 Boston Scientific shares in Q1 2015, an estimated $571K.
  • Americafirst Capital Management first reported a position in Boston Scientific in Q3 2014 and held it in 2 quarters.
  • Americafirst Capital Management's Boston Scientific position peaked at $716K in Q3 2014.
  • 471 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2015.

Based on Americafirst Capital Management's 13F filing for Q1 2015, filed 11 May 2015.